Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: NCI Will Use Genomics Collaborative Data for Hypertension Research

NEW YORK, April 8 - Genomics Collaborative said today that it has agreed to let the US National Cancer Institute use its repository of DNA samples so it can validate some earlier discoveries.

The NCI, which approached GCI in this deal, will use DNA samples from 6,000 people to see if a specific receptor gene increases an individual's risk of developing hypertension. An equal number of samples are from people with and without hypertension.

The project should take three to six months to complete, said Mike Pellini, CEO of GCI. 

Financial terms of the deal, which is the first time GCI has collaborated with the NCI, were not disclosed.

 

And why, pray tell, is the NCI, the nation's top cancer-research facility, studying hypertension? In one of those prized moments of clinical serendipity, NCI researchers, while studying a receptor for HIV, found that knocking out a particular gene appeared to affect blood pressure.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.